• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

AMAG Pharmaceuticals

Anonymous board for AMAG
Replies
10
Views
2K
anonymous
Replies
2
Views
898
anonymous
Replies
0
Views
694
anonymous
Replies
9
Views
2K
anonymous
Replies
19
Views
2K
anonymous
Replies
5
Views
2K
anonymous
Replies
1
Views
830
anonymous
Replies
7
Views
2K
anonymous
Replies
10
Views
2K
anonymous
Replies
4
Views
1K
anonymous
Replies
105
Views
18K
anonymous
Replies
28
Views
6K
anonymous
Replies
373
Views
103K
anonymous
Replies
12
Views
8K
anonymous
Replies
1
Views
1K
anonymous
Replies
9
Views
2K
anonymous
Replies
9
Views
3K
anonymous
Replies
20
Views
8K
anonymous
Replies
9
Views
4K
anonymous